Difference between revisions of "Event:119"
From AOP-Wiki
(Updated summary tables from widget page.) |
|||
Line 9: | Line 9: | ||
== Key Event Overview == | == Key Event Overview == | ||
− | + | Please follow link to [http://134.67.216.63:3001//events/{{PAGENAMEE}} widget page] to edit this section. | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
=== AOPs Including This Key Event === | === AOPs Including This Key Event === | ||
Line 22: | Line 18: | ||
!AOP Name | !AOP Name | ||
− | ! | + | !Event Type |
!Essentiality | !Essentiality | ||
|- | |- | ||
− | |[[Cyclooxygenase inhibition leading reproductive failure]]|| | + | |[[Aop:28|Cyclooxygenase inhibition leading reproductive failure]]||KE|| |
|- | |- | ||
Line 34: | Line 30: | ||
=== Taxonomic Applicability === | === Taxonomic Applicability === | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{|class="wikitable sortable" id="Specproof" | {|class="wikitable sortable" id="Specproof" | ||
− | ! | + | !Name |
!Scientific Name | !Scientific Name | ||
!Evidence | !Evidence | ||
Line 58: | Line 43: | ||
=== Level of Biological Organization === | === Level of Biological Organization === | ||
− | |||
{|class="wikitable sortable" id="BioProof" | {|class="wikitable sortable" id="BioProof" | ||
Line 67: | Line 51: | ||
|} | |} | ||
− | |||
== How this Key Event works == | == How this Key Event works == | ||
Revision as of 18:54, 28 September 2014
Contents
Event Title
Gap, N/A
Short name: Gap, N/A
Key Event Overview
Please follow link to widget page to edit this section.
AOPs Including This Key Event
AOP Name | Event Type | Essentiality |
---|---|---|
Cyclooxygenase inhibition leading reproductive failure | KE |
Taxonomic Applicability
Name | Scientific Name | Evidence | Links |
---|
Level of Biological Organization
Biological Organization |
---|
How this Key Event works
How it is Measured or Detected
Methods that have been previously reviewed and approved by a recognized authority should be included in the Overview section above. All other methods, including those well established in the published literature, should be described here. Consider the following criteria when describing each method: 1. Is the assay fit for purpose? 2. Is the assay directly or indirectly (i.e. a surrogate) related to a key event relevant to the final adverse effect in question? 3. Is the assay repeatable? 4. Is the assay reproducible?